Seeing Is Believing

Currently out of the existing stock ratings of Brandon Folkes, 225 are a BUY (92.21%), 19 are a HOLD (7.79%).
Analyst Brandon Folkes, carries an average stock price target met ratio of 29.96% that have a potential upside of 31.13% achieved within 230 days. Previously, Brandon Folkes worked at HC WAINWRIGHT.
Brandon Folkes’s has documented 474 price targets and ratings displayed on 50 stocks. The coverage was on Healthcare, Energy sectors.
Most recent stock forecast was given on SGMT, Sagimet Biosciences Series A Common Stock.
Analyst best performing recommendations are on EGRX (EAGLE PHARMACEUTICALS).
The best stock recommendation documented was for EGRX (EAGLE PHARMACEUTICALS) at 11/7/2022. The price target of $37 was fulfilled within 1 day with a profit of $2.73 (6.87%) receiving and performance score of 68.71.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$6
$0.41 (7.33%)
$8
4 years 7 months 11 days ago
(25-Feb-2022)
1/4 (25%)
$2.17 (44.83%)
281
Buy Since 09-Jan-2020
$5.6
$0.01 (0.18%)
$5.6
4 years 7 months 21 days ago
(15-Feb-2022)
2/3 (66.67%)
$0.04 (0.72%)
36
Hold Since 10-Nov-2021
$4.5
$-1.09 (-19.50%)
$4.5
4 years 8 months 15 days ago
(21-Jan-2022)
6/7 (85.71%)
$1.14 (33.93%)
152
Buy Since 14-Aug-2018
$6.25
$0.66 (11.81%)
$4.5
5 years 5 months ago
(06-May-2021)
2/3 (66.67%)
$3.07 (96.54%)
228
Buy Since 14-Oct-2015
$8
$2.41 (43.11%)
$21
6 years 10 months 23 days ago
(13-Nov-2019)
0/2 (0%)
$2 (33.33%)
Which stock is Brandon Folkes most bullish on?
Which stock is Brandon Folkes most reserved on?